JTCS Click here to go to SJM website.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Shinichi Toyooka
Takahiro Oto
Shunji Sano
Hiroshi Date
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Toyooka, S.
Right arrow Articles by Date, H.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Toyooka, S.
Right arrow Articles by Date, H.
Related Collections
Right arrow Lung - transplantation

J Thorac Cardiovasc Surg 2009;138:222-226
© 2009 The American Association for Thoracic Surgery


Cardiothoracic Transplantation

Right but not left ventricular function recovers early after living-donor lobar lung transplantation in patients with pulmonary arterial hypertension

Shinichi Toyooka, MDa, Kengo Fukushima Kusano, MDb, Keiji Goto, MDc, Yamane Masaomi, MDa, Takahiro Oto, MDa, Yoshifumi Sano, MDa, Soichiro Fuke, MDb, Megumi Okazaki, RNa, Toru Ohe, MDb, Shingo Kasahara, MDd, Shunji Sano, MDd, Hiroshi Date, MDe,*

a Department of Cancer and Thoracic Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
b Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
c Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
d Department of Cardiovasuclar Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan
e Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, Kyoto, Japan

Received for publication May 8, 2008; revisions received August 8, 2008; accepted for publication February 22, 2009.

* Address for reprints: Hiroshi Date, MD, Department of Thoracic Surgery, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-Cho, Sakyo-Ku, Kyoto 606-8507, Japan. (Email: hdate{at}kuhp.kyoto-u.ac.jp).

Objective: The aim of this study was to evaluate right and left ventricular functions in patients with pulmonary arterial hypertension after living-donor lobar lung transplantation compared with those without hypertension.

Methods: Thirty-three recipients of living-donor lobar lung transplantation were divided into two groups: those with pulmonary arterial hypertension (PAH group; n = 12) and those without (non-PAH group; n = 21). Their systolic pulmonary artery pressure was 93.1 ± 6.7 mm Hg versus 31.4 ± 2.9 mm Hg, respectively. Right and left ventricular ejection fractions, systolic pulmonary artery pressure, and cardiac index were serially measured by radionuclide ventriculography and right heart catheterization, respectively.

Results: Pretransplant right and left ventricular ejection fractions were lower in the PAH group (29.8% ± 7.0%, 49.9% ± 6.6%) than in the non-PAH group (49.7% ± 3.3%, 65.2% ± 1.9%) (P = .010, .068). Two months after living-donor lobar lung transplantation, right ventricular ejection fraction and systolic pulmonary artery pressure in the PAH group (57.3% ± 5.1%, 25.7 ± 1.8 mm Hg) improved dramatically, equal to those in the non-PAH group. In contrast, left ventricular ejection fraction and cardiac index in the PAH group (50.9% ± 3.7%, 2.66 ± 0.12 L · min–1 · m–2) were still significantly lower than in the non-PAH group (65.4% ± 2.8%, 3.13 ± 0.15 L · min–1 · m–2) (P = .0038, .037). At 6 to 12 months, the PAH group demonstrated a significant rise in left ventricular ejection fraction and cardiac index that reached similar values in the non-PAH group measured at 2 months. These values were stable for up to 3 years.

Conclusions: Right ventricular function recovered early after living-donor lobar lung transplantation in the PAH group. In contrast, recovery of left ventricular function required 6 to 12 months. Improved cardiac function was sustained for up to 3 years, suggesting long-term durability of cardiac function recovery after living-donor lobar lung transplantation.



Abbreviations and Acronyms CI = cardiac index; FVC = forced vital capacity; LDLLT = living-donor lobar lung transplantation; LVEF = left ventricular ejection fraction; PAH = pulmonary arterial hypertension; PAP = pulmonary artery pressure; RVEF = right ventricular ejection fraction; sPAP = systolic pulmonary artery pressure








HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The American Association for Thoracic Surgery.